Former FDA Official Reveals Bio-Pharmaceutical Complex on CNN
Dr. Peter Marks Drops Bomb: FDA VRBPAC Key Player in Powerful Syndicate Developing Biological Threats and Countermeasures
By Nicolas Hulscher, MPH and Peter A. McCullough, MD, MPH
A few days ago, ousted FDA official Dr. Peter Marks issued a veiled threat to America about man-made biological threats on national TV:
Peter Marks also confirmed the existence of the Bio-Pharmaceutical Complex. His comments on CNN indicate that there are man-made biological threats and their expensive counter-measures, which as Marks implies, with FDA participation and oversight. His group, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC), was key to rubber-stamping the regulation of vaccines as pandemic counter-measures for public use against the man-made threat, SARS-CoV-2.
We called out the Bio-Pharmaceutical Complex in our book: Courage to Face COVID-19: Preventing Hospitalizations and Death while Battling the Bio-Pharmaceutical Complex:
Who’s in the Bio-Pharmaceutical Complex?
We believe the core members of the Bio-Pharmaceutical Complex include powerful global institutions such as the World Health Organization (WHO), World Economic Forum (WEF), United Nations (UN), UNICEF, UNITAID, UNAIDS, USAID, GAVI, CEPI, the Bill & Melinda Gates Foundation, the Wellcome Trust, the Rockefeller Foundation, EcoHealth Alliance, and others.
Public health authorities including the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the European Medicines Agency (EMA), Australia’s Therapeutic Goods Administration (TGA), South Africa’s Health Products Regulatory Authority (SAHPRA), Japan’s Ministry of Health, Labor, and Welfare (MHLW), Brazilian Health Regulatory Agency (ANVISA) and The Office of the Drugs Controller General of India (DCGI) act as the regulatory backbone of this global apparatus.
Key government and biodefense institutions—including The White House, U.S. Department of Defense, DHS, BARDA, ASPR, ARPA-H, and their international counterparts in China, Brazil, the UK, EU, Japan, Australia, and Canada—serve as the enforcement and operational arms of the Bio-Pharmaceutical Complex. These agencies coordinate pandemic response, fund countermeasures, and increasingly operate under a biosecurity framework that merges public health with national defense.
Major pharmaceutical and biotechnology corporations—such as Pfizer, Moderna, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, Merck, CureVac, CSL Seqirus, and Arcturus Therapeutics—serve as key private sector partners, supplying diagnostics, personal protective equipment, therapeutics, vaccines, and gene-based injectable countermeasures. These companies routinely hire former officials from public health agencies and international bodies, fueling a revolving-door system that erodes regulatory independence and consolidates the power of the Complex.
This pattern is not theoretical—it's well-documented. Nine out of the last ten FDA commissioners went on to work for major pharmaceutical companies shortly after leaving public office. Similarly, officials within the Complex frequently rotate between government agencies, pharmaceutical giants, and global NGOs, using their positions to advance personal careers while deepening institutional entanglements across the syndicate:
Dr. Elizabeth Nabel, former Director of the National Heart, Lung, and Blood Institute (NHLBI) at the NIH — Joined Moderna's Board of Directors.
Dr. Scott Gottlieb, former FDA Commissioner — Joined Board of Pfizer to promote vaccines on TV during pandemic.
Dr. Stephen Hahn, former FDA Commissioner — Became Chief Medical Officer at Flagship Pioneering, the venture capital firm that launched Moderna.
Sir Jonathan Van-Tam, former UK Deputy Chief Medical Officer and member of the Vaccine Task Force — Appointed as Senior Medical Consultant at Moderna.
Dr. Jeremy Farrar, former Director of the Wellcome Trust — Appointed as Chief Scientist at the World Health Organization (WHO).
Dr. Søren Brostrøm, Director General of the Danish Health Authority — Elected to the Executive Board of the World Health Organization.
Dr. Moncef Slaoui, former Chief Scientist of Operation Warp Speed — Previously served as an executive at GlaxoSmithKline (GSK) and as a Board member at Moderna.
Dr. Julie Gerberding, former CDC Director — Became President of Merck Vaccines, later serving as CEO of the Foundation for the National Institutes of Health.
Dr. Luciana Borio, former FDA Acting Chief Scientist and member of the Biden COVID-19 Advisory Board — Became a Partner at ARCH Venture Partners, a firm heavily invested in biotech.
Dr. Patrizia Cavazzoni, former Director of the FDA’s Center for Drug Evaluation and Research (CDER) — Appointed as Chief Medical Officer at Pfizer.
This revolving-door network blurs the line between public health stewardship and corporate profiteering, exposing a deeply embedded conflict of interest that continues to endanger public trust—and public safety. It’s time to dismantle the Bio-Pharmaceutical Complex by declining there penultimate goal, never-ending global mass vaccination.
Epidemiologist and Foundation Administrator, McCullough Foundation
President, McCullough Foundation
www.mcculloughfnd.org
That was one of their most BRAVE posts ever. BRAVO! May our Heavenly Father bless your team and purpose! Amen 🙏🏽
The elephant in the room is emerging.